Subscribe to
our newsletters
Subscribe to our newsletters!
Subscribe to our newsletter and get the latest news from the Nordics straight to your inbox.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form
Search in Nordic Life Science Insight
Life Science
Pharma
Medtech
Biotech
Finance
Companies
Investors
About
Archive
Ebook
Subscribe
Home
Life Science
Pharma
Medtech
Biotech
Finance
Companies
Investors
About
Archive
Ebook
Subscribe
2017
April
May
June
July
August
September
October
November
December
Select month
April
May
June
July
August
September
October
November
December
2018
2019
2017
-
August
Date
Title
Category
Company
August 7, 2017
Read all the key arguments in favor of relocating ema to copenhagen and medicon valley
Life Science
Medicon Valley Alliance
August 7, 2017
Funding Innovation in BioPharma and IT
Life Science
Oslo Cancer Cluster
August 7, 2017
Doing More in Prognosis and Diagnosis
Life Science
Oslo Cancer Cluster
August 9, 2017
Having Chemistry with Chemistry
Life Science
Oslo Cancer Cluster
August 10, 2017
InDex Pharmaceuticals receives orphan-drug designation for pediatric ulcerative colitis in the US
Pharma
InDex Pharmaceuticals
August 16, 2017
Persontilpasset medisin i Arendal
Life Science
Oslo Cancer Cluster
August 22, 2017
Sweden – the top candidate for EMA
Life Science
SwedenBIO
August 28, 2017
Victoza® (liraglutide) is approved in the US as the only type 2 diabetes treatment indicated to reduce the risk of three major adverse cardiovascular events
Pharma
Novo Nordisk Pharmatech A/S
August 29, 2017
InDex Pharmaceuticals Holding AB (publ) interim report January – June 2017
Pharma
InDex Pharmaceuticals
August 31, 2017
Professor Carl Borrebaeck awarded with the BiotechBuilders Award 2017
Biotech
Medicon Valley Alliance
Tweets by NLSInsight